Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7147 USD | -0.54% | -0.03% | +39.37% |
Business Summary
Number of employees: 225
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 64 | 100.0 % | 9 | 100.0 % | -86.51% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 64 | 100.0 % | 9 | 100.0 % | -86.51% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Pascal Touchon
CEO | Chief Executive Officer | 61 | 19-06-23 |
Eric Hyllengren
DFI | Director of Finance/CFO | - | 17-12-31 |
Anhco Nguyen
CTO | Chief Tech/Sci/R&D Officer | 51 | 21-05-09 |
Dan Maziasz
PRN | Corporate Officer/Principal | - | 17-12-31 |
Jill Henrich
LAW | General Counsel | - | - |
K. Murugan
LAW | General Counsel | 49 | 20-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Carol Gallagher
CHM | Chairman | 59 | 12-12-31 |
Eric Dobmeier
BRD | Director/Board Member | 55 | 15-03-25 |
William Heiden
BRD | Director/Board Member | 64 | 15-11-22 |
Matthew Fust
BRD | Director/Board Member | 59 | 14-02-28 |
Director/Board Member | 69 | 20-05-10 | |
Ameet Mallik
BRD | Director/Board Member | 51 | 21-08-08 |
Pascal Touchon
CEO | Chief Executive Officer | 61 | 19-06-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 119,359,230 | 112,322,663 ( 94.10 %) | 0 | 94.10 % |
Company contact information
Atara Biotherapeutics, Inc.
2380 Conejo Spectrum Street Suite 200
91320, Thousand Oaks
+805 623 4211
http://www.atarabio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.37% | 85.77M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- ATRA Stock
- Company Atara Biotherapeutics, Inc.